Volunteer Disclosure Report All relationships are considered compensated. Relationships are self-held unless otherwise noted. Name Employment Leadership Stock and Other Honoraria Consulting or Speakers' Research Funding Patents, Royalties, Other Expert Travel, Other Ownership Advisory Role Bureau Intellectual Property Testimony Accommodations, Interests Expenses Monica M. Bertagnolli Bruce E. Johnson KEW Chugai Pharma Amgen Genentech/Roche (Inst) #Dana-Farber Cancer AstraZeneca Genentech/Roche (Inst) Institute Boehringer GlaxoSmithKline (Inst) Ingelheim Novartis (Inst) Chugai Pharma Toshiba (Inst) KEW Lilly Merck Novartis Clifford A. Hudis Sumanta K. Pal Astellas Astellas Pharma, Medivation Pharma, Aveo, Bristol-Myers Medivation, Squibb, Eisai, Novartis Exelixis, Genentech, Ipsen, Myriad Pharmaceuticals, Novartis, Pfizer Merry Jennifer Markham Astex Astex Pharmaceuticals (Inst), Pharmaceuticals Aduro Biotech (Inst) John Heymach Bio-Tree, Cardinal Abbvie, ARIAD, AstraZeneca (Inst) Spine AstraZeneca, Boehringer Ingelheim, Bristol- Myers Squibb, Calithera Biosciences, Genentech, Medivation, Novartis, Oncomed, Synta Brian Alexander Abbvie, Precision Heath Economics, Schlesinger Associates, Bristol- Myers Squibb Nancy N. Baxter SERVIER Harold J. Burstein Warren A. Chow Novartis Novartis (Inst) William Dale Don Dizon InfiniteMD, UpToDate, Tesaro Merck Sharp & Dohme (Inst) Teva NeuHope Robert Dreicer Astellas Pharma, Genentech (Inst), Asana AstraZeneca, Bristol- Biosciences (Inst) Myers Squibb, Genentech/Roche, EMD Serono, Incyte, Pfizer Andrew S. Epstein UpToDate Patricia Ganz Intrinsic Xenon Pharma (I), Biogen (I) Keryx (I), Silarus Keryx (I) Related to iron Intrinsic LifeSciences LifeSciences (I) Intrinsic Therapeutics (I), metabolism and anemia (I); Keryx (I) LifeSciences (I), InformedDNA, Vifor of chronic disease (I); Up- Silarus Pharma (I), Lilly, to-Date royalties for Therapeutics (I), Gilead Sciences (I), section editor on Teva, Novartis, La Jolla Pharma (I) survivorship Merck, Johnson & Johnson, Pfizer, GlaxoSmithKline, Abbott Laboratories Timothy D. Gilligan WellPoint David L. Graham Medscape Biopep Solution Joshua A. Jones Smitha Krishnamurthi Nektar, Taiho Pharmaceutical, Regeneron, CytomX Therapeutics, Celgene Gary Lyman Generex Halozyme, G1 Amgen (Inst) Biotechnology Therapeutics, Coherus Biosciences Catherine S. Magid Gilead Sciences Bayer, Bristol-Myers Bristol-Myers Squibb (Inst), Diefenbach Squibb, Genentech (Inst), Incyte (Inst), Genentech/Roche, LAM Therapeutics (Inst), Merck, Seattle Merck (Inst), Millennium (Inst), Genetics Seattle Genetics (Inst) Gregory Masters Erica Mayer Myriad Genetics (Inst), Pfizer (Inst) Steven O'Day Bristol-Myers Bristol-Myers Bristol- Merck (Inst), Amgen (Inst), Squibb, Merck, Squibb, Merck, Myers Incyte (Inst) Novartis, Novartis, Amgen Squibb Amgen, Incyte Olatoyosi Odenike CTI/Baxalta, Abbvie, Celgene (Inst), Incyte (Inst), Pfizer, Jazz Astex Pharmaceuticals (Inst), Pharmaceuticals, NS Pharma (Inst), Abbvie (Inst), Gilead Sciences (Inst), Janssen Oncology (Inst), MEI Pharma (Inst), Millennium (Inst), Oncothyrapy (Inst), Agios (Inst), Jyoti Patel ARIAD, Abbvie, AstraZeneca Carlos Rodriguez-Galindo Novimmune Charles Ryan Janssen Bayer, Millennium, BIND Biosciences, Karyopharm Oncology, Ferring Therapeutics, Novartis Astellas Pharma, Bayer Michael S. Sabel Breast Cancer Ally and Melanoma Ally mobile technologies. Lidia Schapira Lynn Mara Schuchter Incyte GlaxoSmithKline (Inst), Merck (Inst), Bristol-Myers Squibb (Inst) Mario Sznol Adaptive Adaptimmune, AcademicC Biotechnologies, Agonox, Alexion ME, Clinical Amphivena, Pharmaceuticals, Care Intensity AstraZeneca/MedI Options, Therapeutics mmune, DAVAOncol Baxalta/Shire, ogy, Biodesix, Bristol- Haymarket Myers Squibb, Media, Genentech/Roche, Imedex, Ignyta, Immune Physician Design, Inovio Education Pharmaceuticals, Resource, Janssen Oncology, Prime Kyowa Hakko Kirin, Oncology, Lilly, Lion Research Biotechnologies, to Practice, Lycera, Merck Sharp TRM & Dohme, Oncology, Modulate, Vindico Molecular Partners, Nektar, Newlink Genetics, Novartis, Omniox, Pfizer, Pierre Fabre, Seattle Genetics, Symphony Evolution, Theravance, Vaccinex Shannon N. Westin AstraZeneca, AstraZeneca, Bayer, Biomarin, BioAscent, Casdin Celgene (I), Critical Outcome Capital, Clovis Technologies, Oncology, GlaxoSmithKline, Karyopharm Genentech, Gerson Therapeutics (I), Kite Pharma Lehrman Group, (I), Merck, Novartis, Tesaro Medivation, Medscape, Ovation Sciences, Roche, Vaniam Group, Vermillion, Watermark Research Partners.